Science Policy Posts

HCI CEO and Director Testifies before Congress on the Value of Federally-Funded Medical Research

HCI CEO and Director Testifies before Congress on the Value of Federally-Funded Medical Research

Mary Beckerle, PhD, CEO and Director of Huntsman Cancer Institute (HCI) at the University of Utah testified before the United States House of Representatives Committee on Oversight and Government Reform. She spoke on the impact of federally-funded cancer research. Beckerle was invited to testify at this bipartisan hearing by Chairman Jason Chaffetz and Ranking Member Elijah Cummings.

Read More

science policy, cancer research

The Importance of Investing in Biomedical Research

The Importance of Investing in Biomedical Research

The 21st Century Cures Act, signed into law in December 2016, includes $4.8 billion to fund research and drug development. The law provided funds for a number of initiatives, including the “Cancer Moonshot” effort, which seeks to accelerate cancer research in the United States. Cancer researchers at HCI urge the community to continue to support biomedical research in order to develop safe and effective disease treatments.

Read More

cancer moonshot, science policy, cancer research